Nicotine attenuates DOI-induced head-twitch response in mice: Implications for tourette syndrome

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 7, 2001, Pages 1445-1457

  Tizabi, Yousef ^a   Russell, Lemuel T ^a   Johnson, Michael ^b   Darmani, Nissar A ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b A T STILL UNIVERSITY   (United States)

Author keywords

DOI; Head twitch; Mecamylamine; Nicotine; Nicotinic receptors; Tourette syndrome

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA BUNGAROTOXIN I 125; CYTISINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; DRUG SELECTIVITY; GILLES DE LA TOURETTE SYNDROME; HEAD TWITCH; MALE; MOUSE; MUSCLE TWITCH; NONHUMAN; PROTEIN BINDING; SHOULDER; STRIATE CORTEX; TIC;

ANIMALS; BRAIN; DRUG ADMINISTRATION SCHEDULE; HEAD MOVEMENTS; INDOPHENOL; MALE; MICE; MICE, INBRED ICR; NICOTINE; NICOTINIC AGONISTS; SEROTONIN AGONISTS; TICS; TOURETTE SYNDROME;

EID: 0034750294     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00194-4     Document Type: Article

References (34)

1. Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: An update
2. 5-Hydroxytryptamine interaction with the nicotinic acetylcholine receptor
3. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
4. Enhancement by 5-hydroxytryptamine and analogues of desensitization of neuronal and muscle nicotinic receptors expressed in Xenopus oocytes
5. Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI
6. 2 receptors?
7. Differential ontogenesis of the DOI-induced behaviors in mice
8. 2A receptors are active under physiological conditions
9. Smoking, nicotine and psychiatric disorders: Evidence for therapeutic role, controversies and implications for future research
10. Long lasting improvement of Tourette's syndrome with transdermal nicotine
11. Blockage of mouse muscle nicotinic receptors by serotonergic compounds
12. Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors
13. Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents
14. 3 receptors expressed in Xenopus oocytes
15. Serotonin and Tourette's syndrome: Movements such as head-shakes and wet-dog shakes may model human tics
16. 2C receptor mutant mice
17. Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptors
18. Presynaptic nicotinic receptors facilitate monoaminergic transmission
19. Pathogenesis of Tourette's syndrome
20. Effects of nicotine and mecamylamine on rat dorsal raphe neurons
21. Block by 5-hydroxytryptamine and apomorphine of recombinant human neuronal nicotinic receptors
22. Effects of parasympathetic drugs on head-twitch response induced by tyramine
23. 2H]5-hydroxytryptamine release from rat striatal synaptosomes
24. Pharmacological consequences ofnicotinergic plus serotonergic manipulations
25. Nicotine addiction and treatment
26. Treatment of Tourette's syndrome with mecamylamine
27. Nicotine for the treatment of Tourette's syndrome
28. Transdermal nicotine for Tourette's syndrome
29. Neurobiology of Tourette syndrome
30. Nicotine blocks quinpirole-induced behavior in rats: Psychiatric implications
31. Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: Psychiatric implications
32. Antidepressant effects of nicotine in an animal model of depression
33. 4 receptor ligands: Relation to antipsychotic action
34. Presynaptic nicotinic ACh receptors